Dr. Hassan A. Haddadin, MD

Dr. Haddadin practices at Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California.

Dr. Haddadin's NPI, 1710918388, was assigned on July 5, 2006. Dr. Haddadin graduated from Other in 1994. Dr. Haddadin holds California license C54163.

Dr. Haddadin's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD, at 28078 Baxter Road, Murrieta, CA 92563.

Dr. Haddadin's primary practice is Pet CT Pob - Positron Emission Tomography, Computed Tomography Professional Office Building - HOPD in Murrieta, California. Dr. Haddadin is also affiliated with Southwest Healthcare Rancho Springs Hospital. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Haddadin to 5 more hospitals, 5 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haddadin practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Haddadin's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Haddadin is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Haddadin's licenses on file in 4 states: California, Arizona, Washington and Nevada.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pleural effusion, pneumonia, pulmonary fibrosis and sleep apnea among the conditions Dr. Haddadin treats.

CMS data shows 1,848 Medicare services from Dr. Haddadin across 12 procedure codes in 2024, for 537 Medicare patients. Medicare paid $190,864 for them.

CMS counts 537 Medicare patients who saw Dr. Haddadin in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haddadin's median patient age at 72, with 50% women.

In 2024, Dr. Haddadin wrote 2,120 Medicare Part D claims for 412 patients. 31% of them were for generic drugs. CMS names the drug for 1,929 of them, across 21 drugs with 11 or more claims each, at $754,956 in total drug cost. In 2023, CMS named 1,463 claims across 21 drugs.

Dr. Haddadin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haddadin as offering telehealth.

Dmand AI links 1 paper to Dr. Haddadin. Dr. Haddadin's most frequent co-author is Henry Charles Bodenheimer, MD.

CMS Open Payments shows 350 general payments to Dr. Haddadin from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $1,298.

Dr. Haddadin graduated from Other in 1994. Dr. Haddadin is a member of AASM, ACCP, SCCM and ACPE.

Dr. Haddadin is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.